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1. Introduction
  Fracture healing is a complex and orderly process. In 
clinical process, the patients of limb fracture combined with 
brain injury have overgrowth and large number of callus, 
and heterotopic ossification appear even in muscle. The 
fracture healing process is significantly faster than patients 
without brain injury[1,2], but the mechanism is still unclear. 
With the development of molecular biology research, we 
have a better understanding of the molecular mechanisms 
of the fracture healing. The local tissues of the fractures 
release a variety of growth factors after a short period of the 
injury, and the bone and cartilage cells still produce the 
growth factor to repair until the late stage. These growth 
factors interact with each other to promote the healing of 
fractures. In clinic, many scholars positively seek the bridge 
factor of the central nervous system and bone metabolism. 
In this study, the changes of epidermal growth factor (EGF) 
and the nerve growth factor (NGF) were studied to explore 
the critical factor which can promote fracture healing.
2. Materials and methods
2.1. General information
   Forty cases of limb fracture combined with brain injury 
were selected from January 2011 to October 2012, The 
diagnostic criteria for the fracture was proved by X-ray. The 
inclusion criteria for the combined traumatic brain injury 
included history of headache, vomiting and coma, which 
persist for more than three days, and CT showing significant 
cerebral contusion. GSM evolutions for patients of limb 
fracture combined with brain injury were from 6 to 12, 
patients' ages were from 21 to 68 years old. The average age 
was 41.3暲8.9, including 25 males and 15 females. The age 
of simple fracture group was from 22 to 70. The average age 
was 41.6暲7.8, including 27 males and 13 females. Age of 
traumatic brain injury group was from 24 to 71, the average 
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age was 41.9暲8.0, including 28 males and 12 females. Age 
of healthy volunteers group was from 21 to 72. The average 
age was 40.6暲8.4, including 24 males and 16 females. All 
patients with serious respiratory, cardiovascular, diabetes, 
bone metabolic diseases, other thoracoabdominal severe 
trauma osteoporosis and osteogenesis imperfecta or other 
foundermental diseases were excluded. 
2.2. Detection method
  A total of 5 mL elbow midvenous blood was collected from 
the enrolled patients in the early morning of 1, 3, 7 and 14 
days after trauma. After blood collection, it was solidified 
at room temperature for 30 min, centrifuged at 3 500 rpm 
for 5 min. The supernatant was collected and then placed 
at -70 曟  refrigerator. EGF and NGF were detected by 
double antibody sandwich ABC-ELISA method (Boster 
anti-human NGF-ELISA kit). Anti-human EGF and NGF 
monoclonal antibody coated the enzyme label plate was 
used; a biotinylated antihuman NGF antibody was added 
to form immune complexes and attached to the board. 
The horseradish peroxidase conjugated Streptavidin was 
combined with the biotin, and an enzyme substrate OPD was 
added; the OD value was proportional to the concentration 
of NGF. The NGF concentration was determined by the 
standard curve.
 
2.3.  Statistical analysis
  The experimental data were analyzed with SPSS16.0 
statistical software. The difference between groups was 
analyzed by 氈
2 test. Data were expressed as mean暲SD 
values. The difference between two groups was analyzed 
with single factor analysis of variance. P<0.05 was regarded 
as statistically significant.
3. Results
  The NGF and EGF levels gradually increased in limb 
fracture combined with brain injury group, traumatic brain 
injury group and simple fracture group. The serum of NGF 
and EGF levels at 1 d, 3 d, 7 d, 14 d after injury in limb 
fracture combined with brain injury group were significantly 
higher than those of the simple fracture group and the 
traumatic brain injury group (P<0.05). The serum of NGF 
and EGF levels at 1 d, 3 d, 7 d, 14 d after injury in traumatic 
brain injury group were significantly higher than the simple 
fracture group (P<0.05) (Table 1, Figure 1 and Figure 2).
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Figure 1. NGF level.                        
1, Limb fracture combined with brain injury group; 2, Traumatic brain 
injury group; 3, Simple fracture group; 4, Normal control group.
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Figure 2. EGF level.
1, Limb fracture combined with brain injury group; 2, Traumatic brain 
injury group; 3, Simple fracture group; 4, Normal control group.
Table 1
mRNA expression levels of NGF and EGF.
Indexes Limb fracture combined with brain injury group Traumatic brain injury group Simple fracture group Normal control group
NGF mRNA 
expression levels
1 d 0.875暲0.135 0.584暲0.104 0.326暲0.087 0.146暲0.049
3 d 0.926暲0.149 0.631暲0.110 0.368暲0.092 0.149暲0.048
7 d 0.957暲0.132 0.684暲0.098 0.399暲0.090 0.152暲0.047
14 d 0.989暲0.138 0.703暲0.112 0.442暲0.091 0.148暲0.046
EGF mRNA 
expression levels
1 d 0.892暲0.145 0.683暲0.132 0.463暲0.110 0.262暲0.084
3 d 0.924暲0.154 0.724暲0.135 0.489暲0.108 0.267暲0.086
7 d 0.963暲0.162 0.763暲0.127 0.532暲0.115 0.265暲0.088
14 d 1.188暲0.149 0.798暲0.125 0.568暲0.121 0.268暲0.089
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4. Discussion
   With increaseing traffic accident, number of trauma 
patients increases year by year, and many of them have 
limb fracture combined with brain injury. Clinical study 
have shown that the fracture healing process of limb 
fracture combined with brain injury is significantly shorter 
than simple fracture. Often there will be more calluses at 
the fracture site after 2 to 3 weeks of injury, and myositis 
ossificans and heterotopic ossification incidence is relatively 
high in traumatic brain injury patients[3,4]. Studies have 
shown[5,6] that the damaged brain tissue or the pituitary 
gland secretes a large number of growth factors and 
inflammatory cells, they can release and secrete a variety 
of cytokines which promote the healing of fractures by fluid 
circulation and paracrine in the fracture ends. And the 
serum of patients with limb fracture combined with brain 
injury can significantly promoting the mitosis of osteoblast 
cells and proliferation of the bone marrow stem cell[7]. It can 
also affect the fluid circulation mediated by brain-derived 
factor, thus further promote the healing of fractures and the 
expression of the correlation factors in the serum.
  NGF is a polypeptide hormone containing 118 amino 
acids, and it plays an important role in survival of nerve 
center and peripheral neurons. It can adjust their growth, 
development and differentiation process[8]. The serum NGF 
levels gradually increased in limb fracture combined with 
brain injury group, traumatic brain injury group and simple 
fracture group. It suggested that a large number of growth 
factors will secreted in the body of the patient's after injury. 
NGF synthesis and release increase in early stage of brain 
injury and bone injury. The serum of NGF levels at 1 d, 
3 d, 7 d, 14 d after injury in limb fracture combined with 
brain injury group were significantly higher than those of 
the simple fracture group and the traumatic brain injury 
group (P<0.05). The serum of NGF levels at 1 d, 3 d, 7 d, 
14 d after injury in the traumatic brain injury group were 
significantly higher than the simple fracture group (P<0.05). 
It suggested that secretion of NGF in patients with limb 
fracture combined with brain injury showed a significant 
upward trend, similar to the research results of Yang[9]. In 
this study, we presume that the secretion of NGF can affect 
the healing of fracture after the trauma of central nervous 
system. The possible mechanism of that is the NGF can 
combine the osteogenic cell membrane receptors, which 
enhanced the activity of the bone cells in the process of 
the phosphorylation of the osteoblasts, and enhanced the 
osteogenic capacity and promoted fracture healing. NGF can 
induced the nerve ingrowth the callus, and can increase the 
local blood supply, so as to promote the bone regeneration.
  EGF is a polypeptide growth factor formed by 53 amino 
acids which is widely distributed in the body. It is a 
powerful broad spectrum cell division promoter[10], and can 
simultaneously act on vascular endothelial cells, fibroblasts 
and osteoblasts. EGF receptor exists in all organizations 
of the human body except the hematopoietic system[11]. 
Kong[12] confirmed the serum EGF concentrations of the 
fracture rabbit increased significantly through establishing 
a fracture model in rabbit, and the concentration differences 
has statistically significant compared with the normal group. 
The serum EGF concentrations of the traumatic brain injury 
group and the simple fracture group show a slow upward 
trend. The serum levels of EGF at 1 d, 3 d, 7 d 14 d after 
injury in limb fracture combined with brain injury group 
were significantly higher than those of the simple fracture 
group and the traumatic brain injury group (P<0.05). The 
serum levels of EGF at 1 d, 3 d, 7 d 14 d after injury of the 
traumatic brain injury group were significantly higher than 
the simple fracture group (P<0.05). That suggested the EGF 
concentrations of the limb fracture combined with brain 
injury group increased significantly, and reached its peak 
after one week of the injury. This study confirmed that 
EGF is closely related to the cells growth, proliferation, 
differentiation, and regeneration of the central nervous 
system. EGF can promote the formation of bone tissue, and 
accelerate the synthesis and deposition of the matrix. Early 
supplement of exogenous NGF and EGF can promote the 
recovery of the central nervous system damage, it can also 
accelerate the healing of bone fractures, which provide a 
new method for the clinical treatment of patients with limb 
fracture combined with brain injury.
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